- “La Parisienne” Goes to the Opera: Maria Callas as Priestess
- Over 40 US Policymakers Commemorate the 50th Dark Anniversary of the Turkish invasion in Cyprus at 39th Annual PSEKA Conference
- Remembering The Turkish Invasion of Cyprus and The Fight to Flee with Famagusta Native and Founder of Aktina FM Elena Maroulleti
- Marc Chagall And Greece: A Love Story
- $17 Million AHEPA Gift Will Open Doors For A Generation Of Students
George Petrocheilos’ Catalio Capital Management launches HealthCor Catalio Acquisition Corp. (NASDAQ: HCAQ)
HealthCor Catalio Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, announced recently the closing of its upsized initial public offering of 20,700,000 Class A ordinary shares at a price of $10.00 per share, including 2,700,000 Class A ordinary shares issued pursuant to the underwriter’s full exercise of its over-allotment option. Total gross proceeds from the offering were $207 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company.
The Company’s sponsor is owned by affiliates of HealthCor Management, L.P., founded by Art Cohen and Joe Healey and manages approximately $2.7 billion in assets across long/short and long only healthcare funds. Catalio Capital Management, LP is a private equity firm that invests in breakthrough biomedical technology companies founded by George Petrocheilos and R. Jacob Vogelstein. The Company is led by Christopher Gaulin, as Chief Executive Officer, Joe Healey, as Chairman and George Petrocheilos, as President.
Catalio Capital Management Co-Founders Dr. Jacob Vogelstein and George Petrocheilos
The Company’s shares began trading on the Nasdaq Capital Market under the ticker symbol “HCAQ” on January 27, 2021.
Jefferies LLC acted as sole book-running manager for the offering. The offering was made only by means of a prospectus.
Related Posts
0 comments